Hironobu Ohmatsu Selected Research

Hironobu Ohmatsu Research Topics

Disease

28	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 02/2002
26	Neoplasms (Cancer) 01/2017 - 01/2002
10	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2016 - 07/2008
5	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2015 - 09/2010
3	Adenocarcinoma of Lung 01/2016 - 10/2013
3	Lung Neoplasms (Lung Cancer) 07/2015 - 02/2004
3	Thymoma (Thymic Carcinoma) 07/2015 - 09/2003
3	Neoplasm Metastasis (Metastasis) 09/2012 - 05/2006
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 06/2012
2	Adenocarcinoma 01/2016 - 06/2012
2	Febrile Neutropenia 10/2015 - 03/2014
2	Pleural Effusion (Pleural Effusions) 04/2011 - 07/2008
2	Cushing Syndrome 01/2011 - 09/2003
2	Neutropenia 07/2007 - 07/2004
2	Phlebitis 03/2007 - 04/2004
1	Malignant Mesothelioma 01/2017
1	Ascites 01/2017
1	Disease Progression 01/2017
1	Tracheal Stenosis 01/2016
1	Anemia 04/2013
1	Lymphoma (Lymphomas) 04/2013
1	Lymphatic Metastasis 01/2013
1	Carcinoma (Carcinomatosis) 03/2012
1	Hemorrhage 01/2012
1	Pericardial Effusion 04/2011
1	Respiratory Insufficiency (Respiratory Failure) 09/2010
1	Radiation Pneumonitis 06/2008
1	Fever (Fevers) 02/2004

Drug/Important Bio-Agent (IBA)

9	Cisplatin (Platino)FDA LinkGeneric 04/2016 - 02/2002
6	PlatinumIBA 01/2017 - 07/2003
6	Gefitinib (Iressa)FDA Link 10/2016 - 01/2006
6	Tyrosine Kinase InhibitorsIBA 01/2016 - 12/2008
6	ErbB Receptors (EGF Receptor)IBA 01/2016 - 01/2006
6	Docetaxel (Taxotere)FDA Link 07/2015 - 02/2002
5	Vinorelbine (Navelbine)FDA LinkGeneric 03/2015 - 04/2004
4	Cadherins (E-Cadherin)IBA 01/2016 - 06/2012
4	Carboplatin (JM8)FDA LinkGeneric 03/2014 - 10/2007
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2016 - 01/2016
3	amrubicinIBA 10/2015 - 09/2010
3	Irinotecan (Camptosar)FDA LinkGeneric 09/2014 - 01/2002
3	Etoposide (VP 16)FDA LinkGeneric 03/2014 - 09/2003
2	ezrinIBA 01/2016 - 07/2015
2	Proteins (Proteins, Gene)FDA Link 07/2015 - 12/2008
2	DNA (Deoxyribonucleic Acid)IBA 09/2014 - 12/2008
2	AnthracyclinesIBA 03/2014 - 09/2010
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2011 - 09/2003
2	Gemcitabine FDA Link 09/2009 - 07/2003
2	Irritants (Vesicants)IBA 03/2007 - 04/2004
1	S-1 plus cisplatinIBA 01/2018
1	Growth Factor ReceptorsIBA 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 10/2016
1	emibetuzumabIBA 10/2016
1	Pemetrexed (MTA)FDA Link 04/2016
1	KalininIBA 01/2016
1	AfatinibIBA 01/2016
1	GemininIBA 04/2015
1	Therapeutic UsesIBA 02/2015
1	Biomarkers (Surrogate Marker)IBA 12/2013
1	Aldehyde Dehydrogenase 1 FamilyIBA 12/2013
1	130-nm albumin-bound paclitaxelIBA 07/2013
1	Darbepoetin alfa (Aranesp)FDA Link 04/2013
1	epoetin betaIBA 04/2013
1	Caveolin 1IBA 01/2013
1	Zoledronic Acid (Zometa)FDA Link 09/2012
1	CateninsIBA 06/2012
1	Differentiation AntigensIBA 06/2012
1	Mitotane (Lysodren)FDA Link 01/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2010
1	ParaffinIBA 12/2008
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2007
1	GlucuronidesIBA 07/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2004
1	Ciprofloxacin (Cipro)FDA LinkGeneric 02/2004
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 02/2004
1	Ceftazidime (Fortum)FDA LinkGeneric 02/2004
1	Amoxicillin (Wymox)FDA LinkGeneric 02/2004
1	Vincristine (Oncovin)FDA LinkGeneric 09/2003
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2003
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 01/2002

Therapy/Procedure

23	Drug Therapy (Chemotherapy) 01/2017 - 07/2003
7	Therapeutics 01/2017 - 07/2008
5	Radiotherapy 01/2018 - 03/2005
4	Combination Drug Therapy (Combination Chemotherapy) 04/2016 - 07/2003
4	Chemoradiotherapy 01/2012 - 06/2008
3	Induction Chemotherapy 01/2017 - 03/2005
2	Aftercare (After-Treatment) 02/2015 - 12/2013
1	Maintenance Chemotherapy 01/2017
1	Palliative Care (Palliative Therapy) 01/2017
1	Proton Therapy 01/2016
1	Neoadjuvant Therapy 12/2013